Humana Inc. (NYSE:HUM) Receives Consensus Recommendation of "Hold" from Brokerages

Shares of Humana Inc. (NYSE:HUM - Get Free Report) have earned a consensus rating of "Hold" from the twenty-three research firms that are presently covering the company, MarketBeat.com reports. Sixteen analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $282.57.

Several equities research analysts recently commented on HUM shares. Wall Street Zen raised shares of Humana from a "hold" rating to a "buy" rating in a research report on Sunday. Guggenheim initiated coverage on shares of Humana in a research note on Wednesday, April 9th. They set a "buy" rating and a $326.00 price objective on the stock. Raymond James Financial upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective on the stock in a research note on Thursday, May 1st. Truist Financial lowered their price objective on shares of Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a research note on Wednesday, July 16th. Finally, Bank of America lowered their price objective on shares of Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a research note on Tuesday, June 17th.

Humana Stock Performance

HUM stock traded down $7.64 during mid-day trading on Thursday, reaching $229.48. 1,231,466 shares of the stock traded hands, compared to its average volume of 1,498,772. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.71. Humana has a 52 week low of $206.87 and a 52 week high of $406.09. The business has a 50-day moving average of $234.55 and a two-hundred day moving average of $256.47. The firm has a market capitalization of $27.70 billion, a PE ratio of 16.23, a P/E/G ratio of 1.62 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, beating the consensus estimate of $10.07 by $1.51. Humana had a net margin of 1.42% and a return on equity of 14.47%. The business had revenue of $32.11 billion for the quarter, compared to analysts' expectations of $32 billion. During the same period in the prior year, the firm earned $7.23 earnings per share. Humana's revenue was up 8.4% compared to the same quarter last year. As a group, equities analysts predict that Humana will post 16.47 EPS for the current fiscal year.

Hedge Funds Weigh In On Humana

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Cary Street Partners Investment Advisory LLC increased its position in shares of Humana by 63.9% during the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock worth $31,000 after buying an additional 46 shares during the period. Riverview Trust Co purchased a new position in shares of Humana in the first quarter worth about $34,000. Garde Capital Inc. purchased a new position in shares of Humana in the first quarter worth $36,000. Zions Bancorporation National Association UT purchased a new position in Humana during the 1st quarter valued at $37,000. Finally, Transce3nd LLC bought a new stake in shares of Humana during the 4th quarter valued at $38,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.